San Francisco, 24 December 2018, Cystic Fibrosis (CF) Therapeutics Market
Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics,
Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And
Segment Forecasts, 2018 - 2025
The global cysticfibrosis therapeutics market is
expected to reach USD 13.9 billion by 2025, according to a new report by Grand
View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally,
research & development activities undertaken by key players, and favorable
initiatives undertaken by nonprofit organizations are expected to boost the
market over the forecast period.
The rising prevalence of CF
indicates the rising demand for treatment alternatives, thereby uplifting the
market. The key players operating in this market in collaboration with
nonprofit organizations focus on the development of novel therapeutics for
treatment. Some of the drugs that are under clinical studies are VX-445 +
tezacaftor + ivacaftor, PTI-428, QR-010, AZD5634, and POL6014.
Favorable initiatives taken by
regional and national nonprofit organizations is one of the key factors
propelling growth. These initiatives ensure support to CF patients. These
organizations aid in research & development activities of these
therapeutics and help improve the quality of life of these patients. For
instance, North American Cystic Fibrosis Conference (NACFC) was formed in 1986
to provide a collaborative and educational forum to CF professionals to share
advances in R&D related to CF therapeutics.
Access Full Research
Report On Cystic Fibrosis (CF) Therapeutics
Market Analysis:
www.grandviewresearch.com/industry-analysis/cystic-fibrosis-cf-therapeutics-market
www.grandviewresearch.com/industry-analysis/cystic-fibrosis-cf-therapeutics-market
Further key findings from the report suggest:
·
The global CF therapeutics
market size was estimated at USD 3,560.5 million in 2016 and is expected to
grow at a CAGR of 16.7% from 2017 to 2025
·
The CFTR modulator segment
emerged as the largest segment in 2016 and the same segment is anticipated to
witness fastest growth over the next 8 years owing to the approval of CFTR
modulator, Orkambi and the presence of various investigational compounds under
the pipeline.
·
Oral route of administration
emerged as the largest segment with revenue of USD 2,266.4 million due to the
ease of administration and convenience
·
North America accounted for the
largest market share owing to the presence of Caucasian descents in this
region. Improved healthcare infrastructure, reimbursements, and initiatives
undertaken by the nonprofit organizations is expected to propel the market over
forecast period,
·
The key players include AbbVie
Inc., F. Hoffmann-La Roche Ltd.; Gilead, Novartis AG, Vertex Pharmaceuticals
Inc., AIT (Advanced Inhalation Therapies), Alaxia, Teva Pharmaceutical
Industries Ltd, Merck & Co. Inc., Alcresta Therapeutics Inc., Allergan, and
AstraZeneca
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
cystic fibrosis therapeutics market on the basis of drug class, route of
administration and region:
Cystic Fibrosis Therapeutics
Drug Class Outlook (Revenue, USD Million, 2014 - 2025)
·
Pancreatic enzyme supplements
·
Mucolytics
·
Bronchodilators
·
CFTR modulators
Cystic Fibrosis Therapeutics
Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)
·
Oral drugs
·
Inhaled drugs
Cystic Fibrosis Therapeutics
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-cystic-fibrosis-cf-therapeutics-market
www.grandviewresearch.com/press-release/global-cystic-fibrosis-cf-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
No comments:
Post a Comment